The Urologist's View of Male Overactive Bladder: Discrepancy between Reality and Belief in Practical Setting.
10.3349/ymj.2010.51.3.432
- Author:
Seung Hwan LEE
1
;
Joon Chul KIM
;
Kyu Sung LEE
;
Jeong Gu LEE
;
Choal Hee PARK
;
Sung Joon HONG
;
Choung Soo KIM
;
Jong Kwan PARK
;
Byung Ha CHUNG
Author Information
1. Department of Urology, Yonsei University College of Medicine, Seoul, Korea. chung646@yuhs.ac
- Publication Type:Original Article
- Keywords:
Overactive bladder;
physician's practice patterns;
bladder outlet obstruction;
benign prostatic hyperplasia;
anticholinergics
- MeSH:
Adrenergic alpha-Antagonists/therapeutic use;
Cholinergic Antagonists/therapeutic use;
*Health Knowledge, Attitudes, Practice;
Humans;
Male;
Physician's Practice Patterns;
Physicians/*psychology;
Prostatic Hyperplasia/diagnosis/drug therapy/pathology;
Questionnaires;
Urinary Bladder Neck Obstruction/diagnosis/drug therapy/pathology;
Urinary Bladder, Overactive/*diagnosis/drug therapy/pathology;
Urinary Retention/diagnosis/drug therapy/pathology;
*Urology
- From:Yonsei Medical Journal
2010;51(3):432-437
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: In order to gain insight into the physicians' awareness of and attitude towards management of overactive bladder (OAB) in males, we performed a nationwide survey of the current strategies that urologists use to diagnose and manage OAB in male patients. MATERIALS AND METHODS: A probability sample was taken from the Korean Urological Association Registry of Physicians, and a random sample of 289 Korean urologists were mailed a structured questionnaire that explored how they manage benign prostatic hyperplasia (BPH). RESULTS: A total of 185 completed questionnaires were returned. The consent rate in the survey was 64.5%. Eighty-one (44%) urologists believed that of all males with lower urinary tract symptoms (LUTS), 20% or more had OAB and 72 (39%) believed that 10-20% had OAB. Half of the urologists surveyed believed that the most bothersome symptom in male OAB patients was nocturia. Seventy-three percent of respondents reported that they prescribed alpha blockers with anticholinergics for first line management, while 19% of urologists prescribed alpha blocker monotherapy but not anticholinergics for OAB patients. Though acute urinary retention (AUR) was considered the anticholinergic adverse event of most concern, the most frequently observed adverse event was dry mouth (95%). CONCLUSION: The present study provides insights into urologist views of male OAB. There is a discrepancy between the awareness of urologists and actual patterns of diagnosis and treatment of male OAB. This finding indicates the need to develop further practical guidelines based on solid clinical data.
